Insecticides India Ltd Valuation Improves Amid Mixed Market Returns

Valuation Metrics Show Positive Momentum

Insecticides India Ltd’s price-to-earnings (P/E) ratio currently stands at 13.79, a figure that positions the stock favourably against many of its industry peers. This P/E is significantly lower than Bayer CropScience’s 24.87 and BASF India’s 26.75, indicating a more reasonable price relative to earnings. The company’s price-to-book value (P/BV) is 1.41, which, while not exceptionally low, remains within an attractive range for investors seeking value in the small-cap pesticides and agrochemicals space.

Enterprise value to EBITDA (EV/EBITDA) is another critical metric where Insecticides India Ltd fares well, with a ratio of 8.40. This compares favourably to Bayer CropScience’s 18.73 and BASF India’s 16.95, suggesting that the company is trading at a more reasonable multiple of its earnings before interest, tax, depreciation, and amortisation. The EV to capital employed ratio of 1.40 and EV to sales of 0.86 further reinforce the stock’s valuation appeal.

These valuation improvements have contributed to the company’s upgrade from a very attractive to an attractive valuation grade, reflecting a more balanced risk-reward profile for investors.

Comparative Analysis with Industry Peers

When compared to its peers, Insecticides India Ltd’s valuation metrics suggest a more conservative pricing. For instance, Anupam Rasayan and Laxmi Organic trade at very expensive levels with P/E ratios of 81.69 and 37.78 respectively, while Sharda Cropchem and Dhanuka Agritech are classified as very attractive with P/E ratios of 11.32 and 14.65. Insecticides India’s P/E of 13.79 places it comfortably within the attractive category, signalling potential undervaluation relative to some competitors.

Moreover, the company’s PEG ratio is 0.00, which may indicate either zero expected earnings growth or a data anomaly, but it contrasts with peers like Bayer CropScience (1.06) and Anupam Rasayan (2.23), which have higher PEG ratios reflecting growth expectations priced into their valuations. This low PEG ratio could appeal to value investors seeking stocks with modest valuations relative to growth prospects.

Return on capital employed (ROCE) and return on equity (ROE) are also important indicators of operational efficiency and profitability. Insecticides India Ltd reports a ROCE of 16.04% and ROE of 12.17%, which are respectable figures in the pesticides and agrochemicals sector, supporting the case for its attractive valuation.

Stock Price and Market Capitalisation Context

The stock closed at ₹597.75 on 31 Aug 2026, up 5.67% from the previous close of ₹565.70. The 52-week trading range spans from ₹525.90 to ₹833.30, indicating some volatility but also room for upside relative to the recent low. Despite this, the company remains classified as a small-cap, which often entails higher risk but also potential for growth.

Insecticides India Ltd’s recent price action shows a recovery from intra-day lows of ₹567.10 to highs of ₹607.20, reflecting investor interest amid valuation improvements. However, the stock’s performance relative to the Sensex has been mixed over various time horizons.

Relative Performance Against Sensex

Over the past week, the stock declined by 2.14%, underperforming the Sensex’s modest fall of 0.36%. The one-month return was down 5.37%, contrasting with the Sensex’s gain of 0.65%. Year-to-date, Insecticides India Ltd has fallen 16.31%, significantly lagging the Sensex’s 9.34% decline. Over the last year, the stock’s return was -26.04%, while the Sensex declined by only 3.52%.

Longer-term returns paint a more positive picture, with the stock delivering 14.84% over three years compared to the Sensex’s 18.87%, and 24.54% over five years against the Sensex’s 37.67%. Over a decade, the stock has appreciated by 92.78%, though this is still below the Sensex’s 178.11% gain. These figures suggest that while the stock has struggled recently, it has delivered reasonable long-term returns, albeit with higher volatility.

Mojo Score and Rating Update

MarketsMOJO assigns Insecticides India Ltd a Mojo Score of 31.0, reflecting a cautious stance on the stock’s prospects. The Mojo Grade has been upgraded from Strong Sell to Sell as of 24 Aug 2026, signalling a slight improvement in the company’s outlook but still indicating a recommendation to avoid or reduce exposure. This rating aligns with the valuation upgrade from very attractive to attractive, suggesting that while the stock is becoming more reasonably priced, underlying concerns remain.

Investors should weigh these factors carefully, considering the company’s small-cap status, sector dynamics, and recent price volatility before making investment decisions.

Outlook and Investor Considerations

Insecticides India Ltd’s improved valuation metrics offer a more compelling entry point for value-oriented investors, especially when compared to more expensive peers in the pesticides and agrochemicals sector. The company’s solid ROCE and ROE figures underpin its operational efficiency, while the relatively low P/E and EV/EBITDA multiples suggest potential undervaluation.

However, the stock’s recent underperformance relative to the Sensex and the modest dividend yield of 0.34% highlight ongoing challenges. The absence of a PEG ratio above zero may also indicate limited growth expectations, which could temper enthusiasm among growth-focused investors.

Given these mixed signals, investors might consider Insecticides India Ltd as part of a diversified portfolio, balancing its attractive valuation against sector risks and broader market conditions.

Conclusion

Insecticides India Ltd’s shift from very attractive to attractive valuation status marks a positive development in its investment profile. The company’s valuation multiples compare favourably with many peers, and its operational returns remain robust. Nonetheless, recent stock price underperformance and a cautious Mojo Grade suggest that investors should remain vigilant and consider alternative opportunities within the sector.

As always, thorough due diligence and alignment with individual risk tolerance are essential when evaluating small-cap stocks in cyclical industries such as pesticides and agrochemicals.

Get 33% Off on our 1 Year Plan - Limited Period Only! Start Today